# Acquired EGFR L718V Mutation and Loss of T790M-Mediated Resistance to Osimertinib in a Patient With NSCLC Who Responded to Afatinib

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/acquired-egfr-l718v-mutation-and-loss-of-t790m-mediated-resistance-to/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Wenfeng Fang,Jiadi Gan,Yihua Huang,Huaqiang Zhou,Li Zhang |
| Citations | 31 |
| DOI | 10.1016/j.jtho.2019.07.018 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086419306033/pdf |
| OpenAlex ID | https://openalex.org/W2991406229 |
| PMID | 31757379 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Yihua Huang](https://scholariq.org/researchers/yihua-huang/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.